share_log

Redhill Biopharma | EFFECT: Others

SEC announcement ·  Feb 16 06:06
Summary by Moomoo AI
RedHill Biopharma Ltd., a company listed on the United States Securities and Exchange Commission (SEC), has achieved a significant milestone with the Notice of Effectiveness issued by the SEC. The notice, which became effective on February 15, 2024, at 4:30 P.M., pertains to the Form F-1 filed by the company. This form is typically used by foreign issuers to register securities for offering in the U.S. market. The effectiveness of this form indicates that RedHill Biopharma has met the necessary regulatory requirements to proceed with its securities offering.
RedHill Biopharma Ltd., a company listed on the United States Securities and Exchange Commission (SEC), has achieved a significant milestone with the Notice of Effectiveness issued by the SEC. The notice, which became effective on February 15, 2024, at 4:30 P.M., pertains to the Form F-1 filed by the company. This form is typically used by foreign issuers to register securities for offering in the U.S. market. The effectiveness of this form indicates that RedHill Biopharma has met the necessary regulatory requirements to proceed with its securities offering.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more